Emerging studies suggest Retatrutide , a dual agonist targeting both GLP-1 and another hormone, appears to represent a notable development for weight loss . Preliminary patient tests have shown https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide